In such case, our clinical data in NSCLC patients treated with conventional radiotherapy plus chemotherapy are in line with the preclinical data highlighting the role of radiotherapy in the proliferation of a stem like CD8+ T-cell population within TDLNs, with potential systemic anti-tumor effect. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.